Diagnostics
New MicroTip Partnership Assays (MPAs) Help Detect the Use of Fentanyl and Tricyclic Antidepressants (TCA)
Tan Tock Seng Hospital and Lucence are developing a next generation decision support tool for liver cancer patients, which aims to reduce the risks associated with liver cancer surgery.
Panel is the only direct-from-blood diagnostic designed to detect genetic markers associated with antibiotic-resistant bloodstream infections
International precision medicine firm Lucence Diagnostics announced that it has received the Clinical Laboratory Improvement Amendments certification for its laboratory in Singapore from the U.S. Department of Health and Human Services’ Centers for Medicare & Medicaid Services.
SphingoTec GmbH announced that novel data on its sphingotest penKid assay for Proenkephalin, a unique and proprietary biomarker for real-time assessment of kidney function, will be presented at the 32nd Annual Congress of the European Society of Intensive Care Medicine taking place in Berlin on September 28 to October 2, 2019.
Special Projects Laboratory opened in EKF’s Cardiff HQ to develop new applications in non-core markets and support other global diagnostics R&D facilities
DiaSorin Molecular LLC announced that it has received CE marking for its Simplexa™ VZV Swab Direct assay.
Todos Medical Ltd. and Orot+ announced the enrollment of the first patient in the pre-commercial launch study of TM-B1 and TM-B2 in Europe.
Graduation underscores the critical progress that T2MR® technology has made in the rapid diagnosis of bacterial infections and accelerating time to appropriate treatment
OncoCyte, a global oncology diagnostics company, recently announced that it will acquire Razor Genomics, which has developed a novel molecular diagnostic test for early-stage non-small cell lung cancer.
PRESS RELEASES
